Naloxone Access: Answering Questions
Virtual Public Meeting 
Tuesday, March 29, 2022
12:30 – 3 PM Eastern Time

 02/17/2022 - 03:00 PM

During our February Therapeutics/Vaccines Lab Meeting we will hear from colleagues at WHO and Gavi, TriNetX, and Kaiser Permanente California discuss ongoing vaccine research. Nevine Zariffa will also join us to discuss what we see in RCTs vs. RWD studies.

This is our once-monthly COVID-19 Evidence Accelerator Therapeutics/Vaccines Lab Meeting. These meetings occur the third Thursday of every month at 3pm ET.

This is the once-monthly COVID-19 Evidence Accelerator Diagnostics Lab Meeting. These meetings occur the third Thursday of every month at 12 pm ET. 

If you are interested in attending the meeting series please email us at evidenceaccelerator@reaganudall.org.

Real-World Data Webinar Series: Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for
Drug and Biological Products
(Guidance for Industry)

Friday, February 11, 2022
11 AM-12 PM Eastern

Real-World Data Webinar Series: Assessing Registries to Support Regulatory
Decision-Making for Drug and Biological Products
(Guidance for Industry)

Friday, January 28, 2022
1-2 PM Eastern

Real-World Data Webinar Series:
Data Standards for Drug and Biological Product Submissions Containing Real-World Data – Draft Guidance for Industry

Friday, December 3, 2021

A Public Webinar
Real-World Data: Assessing Electronic Health Records and Medical Claims Data to Support Regulatory Decision-Making for Drug and Biological Products Guidance for Industry

November 4, 2021

1:30-2:30 pm ET

COVID-19 Lessons Learned: Clinical Evaluation of Therapeutics